搜索
Celldex Therapeutics Inc
CLDX添加自选
37.810USD
-1.170-3.00%
交易中 09/18, 14:33（美东）
2.97B总市值
亏损市盈率 TTM
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Wellington Management Company, LLP
10.29%
Kynam Capital Management LP
7.57%
BlackRock Institutional Trust Company, N.A.
5.80%
Bellevue Asset Management AG
4.61%
Fidelity Management & Research Company LLC
4.32%
其他
67.41%
持股股东
持股股东
占比
Wellington Management Company, LLP
10.29%
Kynam Capital Management LP
7.57%
BlackRock Institutional Trust Company, N.A.
5.80%
Bellevue Asset Management AG
4.61%
Fidelity Management & Research Company LLC
4.32%
其他
67.41%
股东类型
持股股东
占比
Investment Advisor
35.54%
Investment Advisor/Hedge Fund
28.62%
Hedge Fund
26.50%
Venture Capital
2.76%
Research Firm
2.28%
Bank and Trust
0.37%
Individual Investor
0.36%
Pension Fund
0.25%
Insurance Company
0.03%
其他
3.28%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
428
75.58M
96.30%
-6.47M
2025Q4
423
73.56M
131.89%
+1.59M
2025Q3
430
71.99M
131.15%
-2.21M
2025Q2
424
73.79M
132.42%
-1.31M
2025Q1
421
75.04M
133.66%
-13.71M
2024Q4
421
74.73M
125.30%
+1.68M
2024Q3
414
73.10M
121.03%
+1.84M
2024Q2
417
71.21M
123.61%
+212.73K
2024Q1
405
71.18M
106.49%
+1.00M
2023Q4
395
62.54M
112.65%
+8.43M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Wellington Management Company, LLP
8.08M
12.14%
+684.86K
+9.26%
Dec 31, 2025
Kynam Capital Management LP
5.94M
8.93%
-157.55K
-2.58%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
4.55M
6.84%
-2.44K
-0.05%
Dec 31, 2025
Bellevue Asset Management AG
3.62M
5.43%
+60.00K
+1.69%
Dec 31, 2025
Fidelity Management & Research Company LLC
3.39M
5.09%
-160.53K
-4.52%
Dec 31, 2025
State Street Investment Management (US)
3.40M
5.1%
+555.58K
+19.55%
Dec 31, 2025
Commodore Capital LP
2.56M
3.85%
-463.33K
-15.30%
Dec 31, 2025
T. Rowe Price Associates, Inc.
1.96M
2.94%
-346.85K
-15.04%
Dec 31, 2025
Deep Track Capital LP
1.90M
2.86%
-99.26K
-4.96%
Dec 31, 2025
查看更多
ETF 市场
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Simplify Propel Opportunities ETF
3.36%
Virtus LifeSci Biotech Clinical Trials ETF
0.89%
ALPS Medical Breakthroughs ETF
0.74%
State Street SPDR S&P Biotech ETF
0.64%
Direxion Daily S&P Biotech Bull 3X Shares
0.39%
Avantis US Small Cap Equity ETF
0.16%
First Trust Small Cap Growth AlphaDEX Fund
0.15%
Nuveen ESG Small-Cap ETF
0.14%
T Rowe Price Small-Mid Cap ETF
0.13%
Fidelity Fundamental Small-Mid Cap ETF
0.13%
查看更多
Simplify Propel Opportunities ETF
占比3.36%
Virtus LifeSci Biotech Clinical Trials ETF
占比0.89%
ALPS Medical Breakthroughs ETF
占比0.74%
State Street SPDR S&P Biotech ETF
占比0.64%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.39%
Avantis US Small Cap Equity ETF
占比0.16%
First Trust Small Cap Growth AlphaDEX Fund
占比0.15%
Nuveen ESG Small-Cap ETF
占比0.14%
T Rowe Price Small-Mid Cap ETF
占比0.13%
Fidelity Fundamental Small-Mid Cap ETF
占比0.13%